跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 468 条关于
“Chugai Seiyaku Kabushiki Kaisha”
全部
468
临床试验
241
药物
69
机构
47
资讯
111
2年前
Fresenius Kabi Launches First Actemra® Biosimilar in U.S. Market as Biosimilar Landscape Expands
3个月前
AGC Biologics Partners with Teikoku Seiyaku for Novel rhMMP-7 Therapy Manufacturing to Treat Lumbar Disc Herniation
上个月
Energenesis Biomedical and Taiwan Tanabe Seiyaku Enter Joint Development Agreement for Diabetic Foot Ulcer Candidate ENERGI-F703DFU
上个月
Chugai and UCSF Establish Master Collaboration Agreement for Drug Discovery Research
9个月前
Chugai Pharmaceutical Establishes U.S. Partnering Office to Accelerate Global Open Innovation Strategy
7个月前
Chugai Pharmaceutical Licenses Araris' AraLinQ Technology for Next-Generation ADC Development
9个月前
Chugai Secures Japanese Approval for Tecentriq in Rare Thymic Carcinoma
去年
Chugai Pharmaceutical Eyes Combination Therapy to Set New Standard for Obesity Treatment
去年
Rani Therapeutics and Chugai Pharmaceutical Partner to Advance Oral Antibody Delivery Technology
10个月前
Chugai Pharmaceutical Acquires Renalys Pharma for $98 Million to Expand Kidney Disease Portfolio
第 1 页，共 12 页
上一页
下一页
